Petra M. van Ham

733 total citations
11 papers, 503 citations indexed

About

Petra M. van Ham is a scholar working on Virology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Petra M. van Ham has authored 11 papers receiving a total of 503 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Virology, 7 papers in Infectious Diseases and 5 papers in Epidemiology. Recurrent topics in Petra M. van Ham's work include HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (6 papers) and Cytomegalovirus and herpesvirus research (4 papers). Petra M. van Ham is often cited by papers focused on HIV Research and Treatment (10 papers), HIV/AIDS drug development and treatment (6 papers) and Cytomegalovirus and herpesvirus research (4 papers). Petra M. van Ham collaborates with scholars based in Netherlands, Belgium and United States. Petra M. van Ham's co-authors include Monique Nijhuis, Elisabeth Kruse, Emmanuel J. H. J. Wiertz, Robert Jan Lebbink, Ferdy R. van Diemen, Carlijn E. Bruggeling, Anita C. Schürch, Saskia M. Imhof, Marjolein J. G. Hooykaas and Monique Nijhuis and has published in prestigious journals such as PLoS ONE, Clinical Infectious Diseases and Scientific Reports.

In The Last Decade

Petra M. van Ham

11 papers receiving 498 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Petra M. van Ham Netherlands 9 288 185 151 123 99 11 503
Yann Le Duff United Kingdom 8 259 0.9× 117 0.6× 101 0.7× 77 0.6× 63 0.6× 10 421
Ji A. Sohn United States 9 287 1.0× 69 0.4× 394 2.6× 122 1.0× 61 0.6× 9 621
Nathalia Holt United States 3 423 1.5× 217 1.2× 63 0.4× 165 1.3× 60 0.6× 5 668
Li Pan United States 14 171 0.6× 121 0.7× 125 0.8× 143 1.2× 39 0.4× 22 600
Serena Ziglio Italy 6 143 0.5× 394 2.1× 160 1.1× 201 1.6× 78 0.8× 8 525
Dylan Koundakjian United States 3 189 0.7× 48 0.3× 39 0.3× 97 0.8× 37 0.4× 5 292
Ruidong Hao China 8 186 0.6× 21 0.1× 183 1.2× 82 0.7× 33 0.3× 14 376
Juliane Reh Germany 10 81 0.3× 164 0.9× 121 0.8× 77 0.6× 11 0.1× 13 319
Laurence Stensland United States 8 114 0.4× 43 0.2× 357 2.4× 94 0.8× 18 0.2× 10 470
Vanessa B. Soros United States 9 300 1.0× 394 2.1× 201 1.3× 196 1.6× 60 0.6× 13 660

Countries citing papers authored by Petra M. van Ham

Since Specialization
Citations

This map shows the geographic impact of Petra M. van Ham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Petra M. van Ham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Petra M. van Ham more than expected).

Fields of papers citing papers by Petra M. van Ham

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Petra M. van Ham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Petra M. van Ham. The network helps show where Petra M. van Ham may publish in the future.

Co-authorship network of co-authors of Petra M. van Ham

This figure shows the co-authorship network connecting the top 25 collaborators of Petra M. van Ham. A scholar is included among the top collaborators of Petra M. van Ham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Petra M. van Ham. Petra M. van Ham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Mudrikova, Tania, P Schipper, Andy I. M. Hoepelman, et al.. (2024). Characterization of HIV variants from paired Cerebrospinal fluid and Plasma samples in primary microglia and CD4+ T-cells. Journal of NeuroVirology. 30(4). 380–392. 1 indexed citations
2.
Connell, Bridgette J., Lucas E. Hermans, Annemarie M. J. Wensing, et al.. (2020). Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection. Scientific Reports. 10(1). 15866–15866. 24 indexed citations
3.
Wensing, Annemarie M. J., et al.. (2018). Development of sensitive ddPCR assays to reliably quantify the proviral DNA reservoir in all common circulating HIV subtypes and recombinant forms. Journal of the International AIDS Society. 21(9). e25185–e25185. 17 indexed citations
4.
Lebbink, Robert Jan, Femke Wolters, Elisabeth Kruse, et al.. (2017). A combinational CRISPR/Cas9 gene-editing approach can halt HIV replication and prevent viral escape. Scientific Reports. 7(1). 41968–41968. 104 indexed citations
5.
Diemen, Ferdy R. van, Elisabeth Kruse, Marjolein J. G. Hooykaas, et al.. (2016). CRISPR/Cas9-Mediated Genome Editing of Herpesviruses Limits Productive and Latent Infections. PLoS Pathogens. 12(6). e1005701–e1005701. 216 indexed citations
6.
Nijhuis, Monique, et al.. (2015). Comparison of digital PCR platforms and semi-nested qPCR as a tool to determine the size of the HIV reservoir. Scientific Reports. 5(1). 13811–13811. 48 indexed citations
7.
Symons, Jori, Linos Vandekerckhove, Gero Hütter, et al.. (2014). Dependence on the CCR5 Coreceptor for Viral Replication Explains the Lack of Rebound of CXCR4-Predicted HIV Variants in the Berlin Patient. Clinical Infectious Diseases. 59(4). 596–600. 24 indexed citations
8.
Symons, Jori, Art F. Y. Poon, P. Richard Harrigan, et al.. (2013). Maraviroc treatment in non-R5-HIV-1-infected patients results in the selection of extreme CXCR4-using variants with limited effect on the total viral setpoint. Journal of Antimicrobial Chemotherapy. 68(9). 2007–2014. 8 indexed citations
9.
Nijhuis, Monique, Annemarie M. J. Wensing, Petra M. van Ham, et al.. (2011). Impact of the HIV-1 env Genetic Context outside HR1–HR2 on Resistance to the Fusion Inhibitor Enfuvirtide and Viral Infectivity in Clinical Isolates. PLoS ONE. 6(7). e21535–e21535. 15 indexed citations
10.
Symons, Jori, Linos Vandekerckhove, Roger Paredes, et al.. (2011). Impact of triplicate testing on HIV genotypic tropism prediction in routine clinical practice. Clinical Microbiology and Infection. 18(6). 606–612. 22 indexed citations
11.
Symons, Jori, S.F.L. van Lelyveld, A. I. M. Hoepelman, et al.. (2011). Maraviroc is able to inhibit dual-R5 viruses in a dual/mixed HIV-1-infected patient. Journal of Antimicrobial Chemotherapy. 66(4). 890–895. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026